Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
mitú Appoints Vanessa Vigil as President
-
NationGraph Raises $18M Series A to Help Businesses Predict and Win Public Sector Sales
-
Advantage Solutions Appoints Thomas Turner and Frank Yao to Board of Directors
-
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
-
Kratos Awarded $61.1 Million Navy Contract Modification for Full-Rate Production of 70 BQM-177A Subsonic Aerial Targets and Equipment
-
WillScot Announces Nationwide Expansion of Fencing Solutions
-
Ever.green Partners with Corporate Energy Buyers to Support the Deployment of Solar Across 15 West Virginia Schools, Saving the District up to $200,000 in Annual Energy Costs
-
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
-
Shattuck Labs Announces Participation in Upcoming March Investor Conferences
-
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
-
Freshworks to Participate in Upcoming Investor Conferences
-
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
-
Veriff upgrades Marketplace suite to strengthen trust across dual-sided digital ecosystems
-
Century Therapeutics to Participate in Upcoming Investor Conferences in March
-
First Orion Previews April 2026 Global Exchange at Mobile World Congress, Expanding Carrier Connectivity and Adding CAMARA Support
-
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
-
Lightrun Launches Industry’s First AI SRE With Live Dynamic Runtime Context
-
Array Acquires EarnUp to Expand Flexible, Paycheck-Aligned Payment Solutions
-
Prime Medicine to Participate in Upcoming Investor Conferences
-
Lytx, Samsara, Geotab, and Motive Lead ABI Research’s Commercial Video Telematics Ranking
-
ITM to Announce Phase 3 COMPETE Trial Post-Hoc Subgroup Analysis in Pancreatic Neuroendocrine Tumors and Host Satellite Symposium at ENETS 2026
-
Novo Nordisk and Vivtex partner to develop next-generation oral medicines for obesity and diabetes
-
NordStellar enhances its attack surface management feature to help brands prioritize validated threats
-
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
-
Major Shareholder Announcement
-
Ryman Hospitality Properties, Inc. Announces Proposed $700 Million Senior Notes Offering
-
Virtuix and University of Central Florida Reveal Humanoid Robot Controlled Via Omni One Treadmill
-
Humanoid Global Announces Capital Deployment Strategy Outlook for 2026
-
Rio Silver Inc. Announces $3.0 Million Non-Brokered Private Placement Led by Eric Sprott
-
Kura Oncology to Participate in Three Upcoming Investor Conferences
-
NioBay Announces a New Resource Estimate on Its Crevier Project
-
Serve Robotics to Report Fourth Quarter 2025 Financial Results, Host Conference Call and Webcast on March 11
-
Amerigo Announces Strong 2025 Results & Quarterly Dividend
-
Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ™
-
Stock Yards Bancorp Declares Quarterly Cash Dividend of $0.32 per Common Share
-
Dyne Therapeutics to Participate in Upcoming Investor Conferences
-
Wrap Expands into Indian Market Following Purchase Order for DFR-X Non-Lethal Drone Systems, BolaWrap Devices, and WrapReality Virtual Training Systems
-
Medline Reports Fourth Quarter and Full Year 2025 Results
-
Amerigo Announces Strong 2025 Results & Quarterly Dividend
-
Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference
-
Digital Realty Expands Innovation Lab Network to Singapore, Japan and London to Accelerate AI and Hybrid Cloud Implementation
-
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
-
Habit Celebrates Third Restaurant Launch in Torrance
-
Stabilization Notice - Pre Stab - Eutelstat Communications
-
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
-
Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria
-
Astec Reports Fourth Quarter and Full Year 2025 Results
-
EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026
-
Coppernico Completes Gravity and Magnetic Surveys and Refines Large Skarn-Porphyry Targets
-
NexGold Intersects 9.30 g/t Gold Over 11.0 Metres and 2.31 g/t Gold Over 21.5 Metres at the Goldlund Deposit, Ontario

